Skip to main content
Erschienen in: Diabetology International 2/2015

01.06.2015 | Case Report

Type B insulin resistance syndrome with fasting hypoglycemia and postprandial hyperglycemia

verfasst von: Hodaka Yamada, Tomoko Asano, Ikuyo Kusaka, Masafumi Kakei, San-e Ishikawa

Erschienen in: Diabetology International | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Type B insulin resistance syndrome is a rare disease that manifests as severe insulin resistance and hyperglycemia. Few cases with hypoglycemia are reported. We describe a patient with type B insulin resistance syndrome with the presence of insulin receptor antibodies that showed severe hypoglycemia and hyperglycemia and review the clinical features. The patient was a 65-year-old Japanese male diagnosed with type 2 diabetes in June 2012. In August, he was admitted to an emergency room after suffering a hypoglycemic coma several times and then referred to our medical center. His HbA1c was 7.9 %, fasting plasma glucose was 46 mg/dl, and serum insulin level was 310 µU/ml; however, the postprandial glucose level was high (200–400 mg/dl). Plasma glucose decreased slightly after an intravenous 0.1 U/kg insulin challenge test. The findings suggested severe insulin resistance. As anti-insulin receptor antibody was detected (93.3 %, radio-receptor assay), we diagnosed type B insulin resistance syndrome. The patient was administered prednisolone, and the symptoms disappeared. This report details a case of type B insulin resistance syndrome with both hypoglycemia and hyperglycemia, which was successfully treated with only prednisolone.
Literatur
1.
Zurück zum Zitat Kahn CR, Flier JS, Bar RS, et al. The syndrome of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man. N Engl J Med. 1976;294:739–45.PubMedCrossRef Kahn CR, Flier JS, Bar RS, et al. The syndrome of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man. N Engl J Med. 1976;294:739–45.PubMedCrossRef
2.
Zurück zum Zitat Taylor SI, Barbetti F, Accili D, Roth J, Gorden P. Syndromes of autoimmunity and hypoglycemia. Autoantibodies directed against insulin and its receptor. Endocrinol Metab Clin N Am. 1989;18:123–43. Taylor SI, Barbetti F, Accili D, Roth J, Gorden P. Syndromes of autoimmunity and hypoglycemia. Autoantibodies directed against insulin and its receptor. Endocrinol Metab Clin N Am. 1989;18:123–43.
3.
Zurück zum Zitat Taylor SI, Grunberger G, Marcus-Samuels B, et al. Hypoglycemia associated with antibodies to the insulin receptor. N Engl J Med. 1982;307:1422–6.PubMedCrossRef Taylor SI, Grunberger G, Marcus-Samuels B, et al. Hypoglycemia associated with antibodies to the insulin receptor. N Engl J Med. 1982;307:1422–6.PubMedCrossRef
4.
Zurück zum Zitat Di Paolo S, Giorgino R. Insulin resistance and hypoglycemia in a patient with systemic lupus erythematosus: description of antiinsulin receptor antibodies that enhance insulin binding and inhibit insulin action. J Clin Endocrinol Metab. 1991;73:650–7.PubMedCrossRef Di Paolo S, Giorgino R. Insulin resistance and hypoglycemia in a patient with systemic lupus erythematosus: description of antiinsulin receptor antibodies that enhance insulin binding and inhibit insulin action. J Clin Endocrinol Metab. 1991;73:650–7.PubMedCrossRef
5.
Zurück zum Zitat Yamasaki H, Yamaguchi Y, Fujita N, et al. Anti-insulin receptor autoantibodies in a patient with type B insulin resistance and fasting hypoglycemia. Acta Diabetol. 2000;37:189–96.PubMedCrossRef Yamasaki H, Yamaguchi Y, Fujita N, et al. Anti-insulin receptor autoantibodies in a patient with type B insulin resistance and fasting hypoglycemia. Acta Diabetol. 2000;37:189–96.PubMedCrossRef
6.
Zurück zum Zitat Kiyokawa H, Kono N, Hamaguchi T, et al. Hyperinsulinemia due to impaired insulin clearance associated with fasting hypoglycemia and postprandial hyperglycemia: an analysis of a patient with antiinsulin receptor antibodies. J Clin Endocrinol Metab. 1989;69:616–21.PubMedCrossRef Kiyokawa H, Kono N, Hamaguchi T, et al. Hyperinsulinemia due to impaired insulin clearance associated with fasting hypoglycemia and postprandial hyperglycemia: an analysis of a patient with antiinsulin receptor antibodies. J Clin Endocrinol Metab. 1989;69:616–21.PubMedCrossRef
7.
Zurück zum Zitat Arioglu E, Andewelt A, Diabo C, et al. Clinical course of the syndrome of autoantibodies to the insulin receptor (type B insulin resistance). Medicine. 2002;81:87–100.PubMedCrossRef Arioglu E, Andewelt A, Diabo C, et al. Clinical course of the syndrome of autoantibodies to the insulin receptor (type B insulin resistance). Medicine. 2002;81:87–100.PubMedCrossRef
8.
Zurück zum Zitat Zhang S, Wang G, Wang J. Type B insulin resistance syndrome induced by systemic lupus erythematosus and successfully treated with intravenous immunoglobulin: case report and systematic review. Clin Rheumatol. 2013;32:181–8.PubMedCrossRef Zhang S, Wang G, Wang J. Type B insulin resistance syndrome induced by systemic lupus erythematosus and successfully treated with intravenous immunoglobulin: case report and systematic review. Clin Rheumatol. 2013;32:181–8.PubMedCrossRef
10.
Zurück zum Zitat Trischitta V, Wong KY, Brunetti A, et al. Endocytosis, recycling, and degradation of the insulin receptor. Studies with monoclonal antireceptor antibodies that do not activate receptor kinase. J Biol Chem. 1989;264:5041–6.PubMed Trischitta V, Wong KY, Brunetti A, et al. Endocytosis, recycling, and degradation of the insulin receptor. Studies with monoclonal antireceptor antibodies that do not activate receptor kinase. J Biol Chem. 1989;264:5041–6.PubMed
11.
Zurück zum Zitat Karlsson FA, Van Obberghen E, Grunfeld C, Kahn CR. Desensitization of the insulin receptor at an early postreceptor step by prolonged exposure to antireceptor antibody. Proc Natl Acad Sci USA. 1979;76:809–13.PubMedCentralPubMedCrossRef Karlsson FA, Van Obberghen E, Grunfeld C, Kahn CR. Desensitization of the insulin receptor at an early postreceptor step by prolonged exposure to antireceptor antibody. Proc Natl Acad Sci USA. 1979;76:809–13.PubMedCentralPubMedCrossRef
12.
Zurück zum Zitat Coll AP, Thomas S, Mufti GJ. Rituximab therapy for the type B syndrome of severe insulin resistance. N Engl J Med. 2004;350:310–51.PubMedCrossRef Coll AP, Thomas S, Mufti GJ. Rituximab therapy for the type B syndrome of severe insulin resistance. N Engl J Med. 2004;350:310–51.PubMedCrossRef
13.
Zurück zum Zitat Malek R, Chong AY, Lupsa BC, et al. Treatment of type B insulin resistance: a novel approach to reduce insulin receptor autoantibodies. J Clin Endocrinol Metab. 2010;95:3641–7.PubMedCentralPubMedCrossRef Malek R, Chong AY, Lupsa BC, et al. Treatment of type B insulin resistance: a novel approach to reduce insulin receptor autoantibodies. J Clin Endocrinol Metab. 2010;95:3641–7.PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat Hirano T, Adachi M. Insulin-like growth factor 1 therapy for type B insulin resistance. Ann Intern Med. 1997;127:245–6.PubMedCrossRef Hirano T, Adachi M. Insulin-like growth factor 1 therapy for type B insulin resistance. Ann Intern Med. 1997;127:245–6.PubMedCrossRef
15.
Zurück zum Zitat Kawanami D, Ito T, Watanabe Y, et al. Successful control of a case of severe insulin allergy with liraglutide. J Diabetes Investig. 2013;4:94–6.PubMedCentralPubMedCrossRef Kawanami D, Ito T, Watanabe Y, et al. Successful control of a case of severe insulin allergy with liraglutide. J Diabetes Investig. 2013;4:94–6.PubMedCentralPubMedCrossRef
16.
Zurück zum Zitat Kramer N, Rosenstein ED, Schneider G. Refractory hyperglycemia complicating an evolving connective tissue disease: response to cyclosporine. J Rheumatol. 1998;25:816–8.PubMed Kramer N, Rosenstein ED, Schneider G. Refractory hyperglycemia complicating an evolving connective tissue disease: response to cyclosporine. J Rheumatol. 1998;25:816–8.PubMed
Metadaten
Titel
Type B insulin resistance syndrome with fasting hypoglycemia and postprandial hyperglycemia
verfasst von
Hodaka Yamada
Tomoko Asano
Ikuyo Kusaka
Masafumi Kakei
San-e Ishikawa
Publikationsdatum
01.06.2015
Verlag
Springer Japan
Erschienen in
Diabetology International / Ausgabe 2/2015
Print ISSN: 2190-1678
Elektronische ISSN: 2190-1686
DOI
https://doi.org/10.1007/s13340-014-0190-y

Weitere Artikel der Ausgabe 2/2015

Diabetology International 2/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.